IL202287A0 - Therapeutic pyrazolonaphthyridine derivatives - Google Patents
Therapeutic pyrazolonaphthyridine derivativesInfo
- Publication number
- IL202287A0 IL202287A0 IL202287A IL20228709A IL202287A0 IL 202287 A0 IL202287 A0 IL 202287A0 IL 202287 A IL202287 A IL 202287A IL 20228709 A IL20228709 A IL 20228709A IL 202287 A0 IL202287 A0 IL 202287A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic
- pyrazolonaphthyridine
- derivatives
- pyrazolonaphthyridine derivatives
- therapeutic pyrazolonaphthyridine
- Prior art date
Links
- VMPCBEQFWHYVIV-UHFFFAOYSA-N C1=CC=N[C]2N[C]3C=NN=C3C=C21 Chemical class C1=CC=N[C]2N[C]3C=NN=C3C=C21 VMPCBEQFWHYVIV-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94300007P | 2007-06-08 | 2007-06-08 | |
| PCT/US2008/066211 WO2008154447A1 (en) | 2007-06-08 | 2008-06-06 | Therapeutic pyrazolonaphthyridine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL202287A0 true IL202287A0 (en) | 2010-06-16 |
Family
ID=40130166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL202287A IL202287A0 (en) | 2007-06-08 | 2009-11-23 | Therapeutic pyrazolonaphthyridine derivatives |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7858614B2 (enExample) |
| EP (1) | EP2166853B1 (enExample) |
| JP (1) | JP2010529145A (enExample) |
| KR (1) | KR20100036306A (enExample) |
| CN (1) | CN101754681A (enExample) |
| AU (1) | AU2008261803A1 (enExample) |
| BR (1) | BRPI0812369A2 (enExample) |
| CA (1) | CA2689934A1 (enExample) |
| ES (1) | ES2483728T3 (enExample) |
| IL (1) | IL202287A0 (enExample) |
| MX (1) | MX2009013197A (enExample) |
| WO (1) | WO2008154447A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2688405A1 (en) * | 2007-06-08 | 2008-12-18 | Helicon Therapeutics, Inc. | Therapeutic pyrazoloquinoline urea derivatives |
| EP2627655B1 (en) * | 2010-10-14 | 2015-09-16 | Dart Neuroscience (Cayman) Ltd | FUSED 3-OXO-PYRAZOLO[4,3-c]PYRIDINE COMPOUNDS AS GABAA MODULATORS |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| WO2017070481A1 (en) * | 2015-10-23 | 2017-04-27 | Harman International Industries, Incorporated | Dual asymmetric compression driver |
| CN106810550A (zh) * | 2017-01-10 | 2017-06-09 | 湖南华腾制药有限公司 | 一种萘啶衍生物的制备方法 |
| CR20190595A (es) | 2017-06-30 | 2020-03-03 | Bayer Animal Health Gmbh | Nuevos derivados de azaquinolina |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3204126A1 (de) | 1982-02-06 | 1983-08-11 | Bayer Ag, 5090 Leverkusen | Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US4479955A (en) * | 1983-01-10 | 1984-10-30 | Ciba-Geigy Corporation | Heterocycle-fused pyrazolo[3,4-d]pyridin-3-ones as benzodiazepine receptor modulators |
| US4814450A (en) | 1984-07-09 | 1989-03-21 | Ciba-Geigy Corporation | Certain ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives |
| JPS61112075A (ja) | 1984-11-05 | 1986-05-30 | Shionogi & Co Ltd | チエニルピラゾロキノリン誘導体 |
| EP0214092A1 (en) | 1985-08-08 | 1987-03-11 | Ciba-Geigy Ag | Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone |
| US4817450A (en) * | 1987-11-30 | 1989-04-04 | Spedco, Inc. | Pressure/temperature test plug assembly |
| FR2695126B1 (fr) * | 1992-08-27 | 1994-11-10 | Sanofi Elf | Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant. |
| US5334595A (en) | 1992-10-23 | 1994-08-02 | Sterling Winthrop Inc. | Pyrazoloquinolones as anticancer agents |
| AU688515B2 (en) * | 1994-05-24 | 1998-03-12 | F. Hoffmann-La Roche Ag | Tricyclic dicarbonyl derivatives |
| GB9716345D0 (en) * | 1997-08-01 | 1997-10-08 | Merck Sharp & Dohme | Therapeutic compounds |
| GB9716347D0 (en) | 1997-08-01 | 1997-10-08 | Merck Sharp & Dohme | Therapeutic compounds |
| GB9716344D0 (en) * | 1997-08-01 | 1997-10-08 | Merck Sharp & Dohme | Therapeutic compounds |
| TWI271406B (en) | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
| GB0108475D0 (en) * | 2001-04-04 | 2001-05-23 | Merck Sharp & Dohme | New compounds |
| JP3896309B2 (ja) | 2001-07-09 | 2007-03-22 | ファイザー株式会社 | プロテインキナーゼｃ阻害物質としてのピラゾロキノリノン誘導体 |
| ATE425164T1 (de) | 2002-12-16 | 2009-03-15 | Active Biotech Ab | Tetrazyklische immunmodulierende verbindungen |
| TW200508233A (en) | 2003-05-29 | 2005-03-01 | Millennium Pharm Inc | Chk-1 inhibitors |
| CN1893943A (zh) * | 2003-10-03 | 2007-01-10 | 3M创新有限公司 | 吡唑并吡啶和其类似物 |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| AU2006287378A1 (en) * | 2005-09-07 | 2007-03-15 | Braincells, Inc. | Modulation of neurogenesis by HDac inhibition |
| BRPI0812366A2 (pt) * | 2007-06-08 | 2016-08-02 | Helicon Therapeutics Inc | composto, composição farmacêutica e métodos de modulação de um ou mais subtipos de gabaa, de tratamento de deficiência orgânica cognitiva e de desordem psiquiátrica e aumento de função cognitiva em animal e usos do composto ou da composição. |
-
2008
- 2008-06-06 CA CA2689934A patent/CA2689934A1/en not_active Abandoned
- 2008-06-06 JP JP2010511393A patent/JP2010529145A/ja active Pending
- 2008-06-06 US US12/135,045 patent/US7858614B2/en not_active Expired - Fee Related
- 2008-06-06 WO PCT/US2008/066211 patent/WO2008154447A1/en not_active Ceased
- 2008-06-06 EP EP08770412.8A patent/EP2166853B1/en not_active Not-in-force
- 2008-06-06 BR BRPI0812369A patent/BRPI0812369A2/pt not_active IP Right Cessation
- 2008-06-06 AU AU2008261803A patent/AU2008261803A1/en not_active Abandoned
- 2008-06-06 CN CN200880025152A patent/CN101754681A/zh active Pending
- 2008-06-06 KR KR1020107000331A patent/KR20100036306A/ko not_active Withdrawn
- 2008-06-06 MX MX2009013197A patent/MX2009013197A/es active IP Right Grant
- 2008-06-06 ES ES08770412.8T patent/ES2483728T3/es active Active
-
2009
- 2009-11-23 IL IL202287A patent/IL202287A0/en unknown
-
2010
- 2010-11-18 US US12/949,619 patent/US8497262B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0812369A2 (pt) | 2016-08-09 |
| US7858614B2 (en) | 2010-12-28 |
| CN101754681A (zh) | 2010-06-23 |
| US20090005365A1 (en) | 2009-01-01 |
| JP2010529145A (ja) | 2010-08-26 |
| HK1142774A1 (en) | 2010-12-17 |
| MX2009013197A (es) | 2010-04-27 |
| EP2166853B1 (en) | 2014-05-28 |
| CA2689934A1 (en) | 2008-12-18 |
| EP2166853A4 (en) | 2011-04-06 |
| AU2008261803A1 (en) | 2008-12-18 |
| US20110065692A1 (en) | 2011-03-17 |
| EP2166853A1 (en) | 2010-03-31 |
| ES2483728T3 (es) | 2014-08-07 |
| WO2008154447A1 (en) | 2008-12-18 |
| US8497262B2 (en) | 2013-07-30 |
| KR20100036306A (ko) | 2010-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL205759A0 (en) | Isoxazolo-pyridine derivatives | |
| IL205753A0 (en) | Isoxazolo-pyridazine derivatives | |
| IL202020A0 (en) | Spiroindolinone derivatives | |
| ZA201000431B (en) | Indazolamide derivatives | |
| IL205755A0 (en) | Isoxazolo-pyrazine derivatives | |
| IL200618A0 (en) | Aza-pyridopyrimidinone derivatives | |
| GB0813087D0 (en) | Therapeutic compounds | |
| GB0716532D0 (en) | Therapeutic compounds | |
| IL202667A0 (en) | Isoxazole-imidazole derivatives | |
| GB0719518D0 (en) | Therapy | |
| PL2245028T3 (pl) | Pochodne 5-aminocyklilometyloksazolidyn-2-onu | |
| EP2133347A4 (en) | 1-BIARYLAZETIDINONDERIVATE | |
| IL202287A0 (en) | Therapeutic pyrazolonaphthyridine derivatives | |
| IL202463A0 (en) | Sulfonyl-quinoline derivatives | |
| IL202159A0 (en) | Piperidine-amide derivatives | |
| GB0702862D0 (en) | Therapeutic compounds | |
| GB0808690D0 (en) | Therapeutic use | |
| GB0708188D0 (en) | Therapeutic compounds | |
| GB0708186D0 (en) | Therapeutic compounds | |
| GB0716072D0 (en) | Therapy | |
| GB0700635D0 (en) | Therapy | |
| GB0724635D0 (en) | Therapeutic compounds | |
| GB0722401D0 (en) | Therapeutic compounds | |
| GB0717568D0 (en) | Therapeutic compounds | |
| GB0713865D0 (en) | Therapeutic compounds |